NEWSR
FDA feedback gives Oncolytics a possible route for REO 033 in colorectal cancer, but the next decision still depends on interim data from a 60-patient randomized study.
The 2026 Nara Organics formula recall shows why removing products from commerce is only one part of consumer protection. The harder question is whether affected households can be identified and reached.
The FDA’s AI-enabled device list is expanding rapidly, but authorization alone does not establish broad real-world performance. The next test is stronger evidence and clearer lifecycle oversight.
The 2026 push to delay FDA food-traceability enforcement could reduce near-term compliance pressure while extending uncertainty for food businesses and consumers.
The FDA’s food traceability requirements are barred from enforcement until July 20, 2028. The delay may reduce near-term compliance pressure while extending uncertainty over how quickly investigators can trace high-risk foods.
The expanding Cyclospora outbreak shows why traceback, recall identifiers and careful consumer guidance matter as much as a single laboratory result.
